Diagnostic testing of eczematous dermatitis with incomplete response to dupilumab
- PMID: 35367296
- DOI: 10.1016/j.jaad.2022.03.047
Diagnostic testing of eczematous dermatitis with incomplete response to dupilumab
Keywords: allergic contact dermatitis; atopic dermatitis; cutaneous lupus; dermatology; dupilumab; patch testing; photodermatitis; polymorphous light eruption.
Conflict of interest statement
Conflicts of interest Dr Murase has participated in Advisory Boards for Genzyme/Sanofi, Eli Lilly, Dermira, LeoPharma, and UCB; participated in disease statement management talks for Regeneron and UCB; and provided dermatologic consulting services for UpToDate. Drs Ashbaugh and Botto and Author Bai have no conflicts of interest to declare.
Comment in
-
Comment on "Diagnostic testing of eczematous dermatitis with incomplete response to dupilumab".J Am Acad Dermatol. 2022 Dec;87(6):e241-e242. doi: 10.1016/j.jaad.2022.05.069. Epub 2022 Aug 4. J Am Acad Dermatol. 2022. PMID: 35933070 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
